SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-033915
Filing Date
2017-02-08
Accepted
2017-02-08 08:01:50
Documents
41
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d336012d10q.htm 10-Q 235905
2 EX-31.1 d336012dex311.htm EX-31.1 8991
3 EX-31.2 d336012dex312.htm EX-31.2 8728
4 EX-32.1 d336012dex321.htm EX-32.1 5186
  Complete submission text file 0001193125-17-033915.txt   1952048

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT meip-20161231.xml EX-101.INS 250439
6 XBRL TAXONOMY EXTENSION SCHEMA meip-20161231.xsd EX-101.SCH 26651
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meip-20161231_cal.xml EX-101.CAL 30935
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meip-20161231_def.xml EX-101.DEF 167583
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20161231_lab.xml EX-101.LAB 247488
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20161231_pre.xml EX-101.PRE 193447
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 17580952
SIC: 2834 Pharmaceutical Preparations